Cited by 226Psychedelics and Drug StudiesAlkaloids: synthesis and pharmacologySynthesis and bioactivity of alkaloids

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.

Ayahuasca: Pharmacology, neuroscience and therapeutic potential

Domínguez-Clavé, Elisabet, Soler, Joaquim, Elices, Matilde, Pascual, Juan C., Álvarez, Enrique, de la Fuente Revenga, Mario, Friedlander, Pablo, Feilding, Amanda, Riba, Jordi·2016·Brain Research Bulletin

DOI 10.1016/j.brainresbull.2016.03.002

Open this paper in CoChat — free account

Abstract

Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and used for ritual purposes by the indigenous populations of the Amazon. The use of a variation of the tea that combines B. caapi with the leaves of the shrub Psychotria viridis has experienced unprecedented expansion worldwide for its psychotropic properties. This preparation contains the psychedelic 5-HT 2A receptor agonist N,N-dimethyltryptamine (DMT) from P. viridis, plus β-carboline alkaloids with monoamine-oxidase-inhibiting properties from B. caapi. Acute administration induces a transient modified state of consciousness characterized by introspection, visions, enhanced emotions and recollection of personal memories. A growing body of evidence suggests that ayahuasca may be useful to treat substance use disorders, anxiety and depression. Here we review the pharmacology and neuroscience of ayahuasca, and the potential psychological mechanisms underlying its therapeutic potential. We discuss recent findings indicating that ayahuasca intake increases certain mindfulness facets related to acceptance and to the ability to take a detached view of one's own thoughts and emotions. Based on the available evidence, we conclude that ayahuasca shows promise as a therapeutic tool by enhancing self-acceptance and allowing safe exposure to emotional events. We postulate that ayahuasca could be of use in the treatment of impulse-related, personality and substance use disorders and also in the handling of trauma. More research is needed to assess the full potential of ayahuasca in the treatment of these disorders.

Integrity signals

Registry

Crossref · 10.1016/j.brainresbull.2016.03.002

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Using Self-Report Assessment Methods to Explore Facets of Mindfulness
Baer, R. A., Smith, G. T., Hopkins, J., Krietemeyer, J., & Toney, L. (2006) · Assessment · doi:10.1177/1073191105283504 · Cited by 7,511 · cited 4×
“, 2016), are the acceptance-measuring components of FFMQ (Baer et al., 2006).”
BackgroundMethodInfluential
A theory of cortical responses.
Friston, K. (2005) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1622 · Cited by 4,578
Mechanisms of mindfulness
Shapiro, S. L., Carlson, L. E., Astin, J. A., & Freedman, B. (2006) · Journal of Clinical Psychology · doi:10.1002/jclp.20237 · Cited by 4,002
Metacognitive awareness and prevention of relapse in depression: Empirical evidence
Teasdale, J. D., Moore, R. G., Hayhurst, H., Pope, M., Williams, S., & Segal, Z. V. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.2.275 · Cited by 1,221
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
Simultaneous EEG and fMRI of the alpha rhythm
Goldman, R. I., Stern, J. M., Engel, J., & Cohen, M. S. (2002) · Neuroreport · doi:10.1097/00001756-200212200-00022 · Cited by 1,131
EEG-correlated fMRI of human alpha activity
Laufs, H., Kleinschmidt, A., Beyerle, A., Eger, E., Salek-Haddadi, A., Preibisch, C., & Krakow, K. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00286-6 · Cited by 1,025
Simultaneous EEG and fMRI of the alpha rhythm
Stern (2002) · Neuroreport · doi:10.1097/01.wnr.0000047685.08940.d0 · Cited by 945
The Assessment of Present-Moment Awareness and Acceptance: The Philadelphia Mindfulness Scale
Cardaciotto, L., Herbert, J. D., Forman, E. M., Moitra, E., & Farrow, V. (2008) · Assessment · doi:10.1177/1073191107311467 · Cited by 940
A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories
Jones, M. W., Errington, M. L., French, P. J., Fine, A., Bliss, T., Garel, S., Charnay, P., Bozon, B., Laroche, S., & Davis, S. (2001) · Nature Neuroscience · doi:10.1038/85138 · Cited by 925
Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Untitled work
(1990) · Medical Entomology and Zoology · Cited by 842
Initial Psychometric Properties of the Experiences Questionnaire: Validation of a Self-Report Measure of Decentering
Fresco, D. M., Moore, M. T., van Dulmen, M. H. M., Segal, Z. V., Ma, S. H., Teasdale, J. D., & Williams, J. M. G. (2007) · Behavior Therapy · doi:10.1016/j.beth.2006.08.003 · Cited by 810 · cited 4×
“These studies have reported greater gains in decentering with psychotherapeutic interventions than with antidepressant medications in drug-responders (Fresco et al., 2007).”
BackgroundMethodInfluential
Spontaneous Fluctuations in Posterior -Band EEG Activity Reflect Variability in Excitability of Human Visual Areas
Romei, V., Brodbeck, V., Michel, C. M., Amedi, A., Pascual‐Leone, Á., & Thut, G. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm229 · Cited by 717
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & MCKENNEY, J. D. J. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 635
On the Role of Prestimulus Alpha Rhythms over Occipito-Parietal Areas in Visual Input Regulation: Correlation or Causation?
Romei, V., Groß, J., & Thut, G. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0160-10.2010 · Cited by 624
Correlates of alpha rhythm in functional magnetic resonance imaging and near infrared spectroscopy
Moosmann, M., Ritter, P., Krastel, I., den Brink, A. M.-V., Thees, S., Blankenburg, F., Taskin, B., Obrig, H., & Villringer, A. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00344-6 · Cited by 595
The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535
Cognitive factors involved in the onset and maintenance of posttraumatic stress disorder (PTSD) after physical or sexual assault.
Dunmore, E., Clark, D., & Ehlers, A. (1999) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(98)00181-8 · Cited by 512
Broadband Cortical Desynchronization Underlies the Human Psychedelic State
Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R., Brookes, M. J., Williams, T. M., Errtizoe, D., Sessa, B., Papadopoulos, A., Bolstridge, M., Singh, K. D., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2063-13.2013 · Cited by 499
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Osório, F. D. L., Sanches, R. F., Macedo, L. R., dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A., & Hallak, J. E. (2015) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2014-1496 · Cited by 488
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study
Sanches, R. F., de Lima Osório, F., dos Santos, R. G., Macedo, L. R. H., Maia-de-Oliveira, J. P., Wichert-Ana, L., de Araujo, D. B., Riba, J., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000436 · Cited by 466
The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience
O’Donovan, K. J., Tourtellotte, W. G., Milbrandt, J., & Baraban, J. M. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01343-5 · Cited by 457
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Gasser, P., Kirchner, K., & Passie, T. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114555249 · Cited by 456
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis
Vollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444
Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of ayahuasca
McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90003-5 · Cited by 398
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049882 · Cited by 390
Dysfunctional meaning of posttraumatic intrusions in chronic PTSD.
Steil, R., & Ehlers, A. (2000) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(99)00069-8 · Cited by 372
Prolonged exposure therapy: past, present, and future
Foa, E. B. (2011) · Depression and Anxiety · doi:10.1002/da.20907 · Cited by 358
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V. J., & Guillén, H. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.12.019 · Cited by 357 · cited 1×
“In humans, they can reversibly block the activity of subtype A of the monoamine-oxidase (MAO) enzyme (Undenfriend et al., 1958; Buckholtz and Boggan, 1977a, Wang et al., 2010; Herraiz et al., 2010).”
Background
Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
Kometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-12.2013 · Cited by 355
Dialectical Behaviour Therapy for Post-traumatic Stress Disorder after Childhood Sexual Abuse in Patients with and without Borderline Personality Disorder: A Randomised Controlled Trial
Bohus, M., Dyer, A. S., Priebe, K., Krüger, A., Kleindienst, N., Schmahl, C., Niedtfeld, I., & Steil, R. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000348451 · Cited by 344 · cited 1×
“…mechanisms suggest its potential to treat trauma-related conditions and other disorders like borderline personality disorder (Bohus et al., 2011, Bohus et al., 2013, Harner and Burgess, 2011; Harner et al, 2015), obsessive-compulsive disorder (OCD), and phobias, in a structured, safe and…”
Background
Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.
GROB, C. S., McKENNA, D. J., CALLAWAY, J. C., BRITO, G. S., NEVES, E. S., OBERLAENDER, G., SAIDE, O. L., LABIGALINI, E., TACLA, C., MIRANDA, C. T., et al. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199602000-00004 · Cited by 338
Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada
Thomas, G., Lucas, P., Capler, N., Tupper, K., & Martin, G. (2013) · Current Drug Abuse Reviews · doi:10.2174/15733998113099990003 · Cited by 330
Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (2001) · Psychopharmacology · doi:10.1007/s002130000606 · Cited by 303
Self-citation
Resting electroencephalogram alpha-power over posterior sites indexes baseline visual cortex excitability
Romei, V., Rihs, T., Brodbeck, V., & Thut, G. (2008) · NeuroReport · doi:10.1097/wnr.0b013e3282f454c4 · Cited by 285
An Open Trial of an Acceptance-Based Behavior Therapy for Generalized Anxiety Disorder
Roemer, L., & Orsillo, S. M. (2007) · Behavior Therapy · doi:10.1016/j.beth.2006.04.004 · Cited by 282 · cited 1×
“In addition to substance use disorders, there is growing empirical evidence of the effectiveness of acceptance-based therapies in the treatment of anxiety disorders and trauma (Roemer and Orsillo, 2007; Skanavi et al., 2011; Vujanovic et al., 2009).”
Background
Psychometric properties of the Spanish validation of the Five Facets of Mindfulness Questionnaire (FFMQ)
Cebolla, A., García-Palacios, A., Soler, J., Guillen, V., Baños, R., & Botella, C. (2012) · The European Journal of Psychiatry · doi:10.4321/s0213-61632012000200005 · Cited by 263
Self-citation
Untitled work
(2005) · Cited by 262
The hemodynamic response of the alpha rhythm: An EEG/fMRI study
de Munck, J. C., Goncalves, S. I., Huijboom, L., Kuijer, J. P. A., Pouwels, P. J. W., Heethaar, R. M., & Lopes, F. H. D. S. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.022 · Cited by 260
Relationship of posttreatment decentering and cognitive reactivity to relapse in major depression
Fresco, D. M., Segal, Z. V., Buis, T., & Kennedy, S. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.447 · Cited by 256
Treatment-specific changes in decentering following mindfulness-based cognitive therapy versus antidepressant medication or placebo for prevention of depressive relapse.
Bieling, P. J., Hawley, L. L., Bloch, R. T., Corcoran, K. M., Levitan, R. D., Young, L. T., MacQueen, G. M., & Segal, Z. V. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0027483 · Cited by 241
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
Riba, J., Romero, S., Grasa, E., Mena, E., Carrió, I., & Barbanoj, M. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0358-7 · Cited by 241
Seeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion.
de Araujo, D. B., Ribeiro, S., Cecchi, G. A., Carvalho, F. M., Sanchez, T. A., Pinto, J. P., de Martinis, B. S., Crippa, J. A., Hallak, J. E. C., & Santos, A. C. (2012) · Human Brain Mapping · doi:10.1002/hbm.21381 · Cited by 239
Assessment of addiction severity among ritual users of ayahuasca.
Fábregas, J. M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P. C. R., Alcázar-Córcoles, M. Á., Barbanoj, M. J., Riba, J., & Bouso, J. C. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.03.024 · Cited by 227
Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG
Gouzoulis-Mayfrank, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00089-x · Cited by 219
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.
Bouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., & Riba, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.008 · Cited by 218
Resting state networks in major depressive disorder
Dutta, A., McKie, S., & Deakin, J. F. W. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.10.003 · Cited by 218
Effects of mindfulness on meta-awareness and specificity of describing prodromal symptoms in suicidal depression
Hargus, E., Crane, C., Barnhofer, T., & Williams, J. M. G. (2010) · Emotion · doi:10.1037/a0016825 · Cited by 212
The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper, K. W. (2008) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.11.001 · Cited by 212
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members
SANTOS, R. G. D., Landeira-Fernández, J., Strassman, R. J., Motta, V., & Cruz, A. P. D. M. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.04.012 · Cited by 212
Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities
Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4162-0 · Cited by 209
Self-citation
Dimethyltryptamin: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism
Szára, S. (1956) · Cellular and Molecular Life Sciences · doi:10.1007/bf02157378 · Cited by 203
Change in Decentering Mediates Improvement in Anxiety in Mindfulness-Based Stress Reduction for Generalized Anxiety Disorder
Hoge, E. A., Bui, E., Goetter, E., Robinaugh, D. J., Ojserkis, R. A., Fresco, D. M., & Simon, N. M. (2015) · Cognitive Therapy and Research · doi:10.1007/s10608-014-9646-4 · Cited by 188 · cited 2×
“…et al., 2007b; Gecht, 2014; Hargus et al., 2010; Teasdale et al., 2002), but also in generalized anxiety disorder (Hayes-Skelton et al., 2015; Hoge et al., 2015), social anxiety (Hayes-Skelton and Graham, 2013), eating disorders, substance use disorders (Shapiro et al., 2006; Soler et al.,…”
Background
“Ayahuasca,” the South American hallucinogenic drink: An ethnobotanical and chemical investigation
Rivier, L., & Lindgren, J. (1972) · Economic Botany · doi:10.1007/bf02860772 · Cited by 186
Monoamine oxidase inhibition in brain and liver produced by β-carbolines: structure-activity relationships and substrate specificity
Buckholtz, N. S., & Boggan, W. O. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90007-7 · Cited by 185
Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research
Hermle, L., Fünfgeld, M., Oepen, G., Botsch, H., Borchardt, D., Gouzoulis, E., Fehrenbach, R. A., & Spitzer, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90059-9 · Cited by 183
Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compounds
Udenfriend, S., Witkop, B., Redfield, B. G., & Weissbach, H. (1958) · Biochemical Pharmacology · doi:10.1016/0006-2952(58)90025-x · Cited by 174
Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans
Valle, M., Maqueda, A. E., Rabella, M., Rodríguez-Pujadas, A., Antonijoan, R. M., Romero, S., Alonso, J. F., Mañanas, M. À., Barker, S., Friedlander, P., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.012 · Cited by 173
Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test
Farzin, D., & Mansouri, N. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.08.005 · Cited by 171
Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling AND Játiva-M.)
Valdés, L. J., Díaz, J., & Paul, A. G. (1983) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(83)90004-1 · Cited by 166
Representation, inference, and transcendent encoding in neurocognitive networks of the human brain
Mesulam, M. M. (2008) · Annals of Neurology · doi:10.1002/ana.21534 · Cited by 166
Plants of the Gods: Origins of Hallucinogenic Use
Brenan, J. P. M., Schultes, R. E., & Hofmann, A. (1980) · Kew Bulletin · doi:10.2307/4110029 · Cited by 154
Interactions between different EEG frequency bands and their effect on alpha - fMRI correlations
de Munck, J. C., Goncalves, S. I., Mammoliti, R., Heethaar, R. M., & Lopes, F. H. D. S. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.029 · Cited by 150
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
Fortunato, J. J., Réus, G. Z., Kirsch, T. R., Stringari, R. B., Stertz, L., Kapczinski, F., Pinto, J. P., Hallak, J. E., Zuardi, A. W., Crippa, J. A., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.021 · Cited by 150
Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors
Smith, R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00110-5 · Cited by 147
Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter
Cozzi, N. V., Gopalakrishnan, A., Anderson, L. L., Feih, J. T., Shulgin, A. T., Daley, P. F., & Ruoho, A. E. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0308-8 · Cited by 144
Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca
SANTOS, R. G. D., Valle, M., Bouso, J. C., Nomdedeu, J. F., Rodrı́guez-Espinosa, J., McIlhenny, E. H., Barker, S. A., Barbanoj, M. J., & Riba, J. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823607f6 · Cited by 143
Pharmacology of ayahuasca administered in two repeated doses
dos Santos, R. G., Grasa, E., Valle, M., Ballester, M. R., Bouso, J. C., Nomdedéu, J. F., Homs, R., Barbanoj, M. J., & Riba, J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2434-x · Cited by 141
Mindfulness-based acceptance and posttraumatic stress symptoms among trauma-exposed adults without axis I psychopathology
Vujanovic, A. A., Youngwirth, N. E., Johnson, K. A., & Zvolensky, M. J. (2009) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2008.08.005 · Cited by 137 · cited 1×
“In addition to substance use disorders, there is growing empirical evidence of the effectiveness of acceptance-based therapies in the treatment of anxiety disorders and trauma (Roemer and Orsillo, 2007; Skanavi et al., 2011; Vujanovic et al., 2009).”
Background
Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography
Riba, J., Anderer, P., Jané, F., Saletu, B., & Barbanoj, M. J. (2004) · Neuropsychobiology · doi:10.1159/000077946 · Cited by 134
Decentering as a Common Link among Mindfulness, Cognitive Reappraisal, and Social Anxiety
Hayes-Skelton, S., & Graham, J. (2013) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465812000902 · Cited by 134
Untitled work
(2008) · PubMed · Cited by 130
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles
Baumeister, D., Barnes, G. L., Giaroli, G., & Tracy, D. K. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314527985 · Cited by 127
Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers
Riba, J., Anderer, P., Morte, A., Urbano, G., Jané, F., Saletu, B., & Barbanoj, M. J. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01609.x · Cited by 125
Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
Adayev, T., Węgiel, J., & Hwang, Y. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.024 · Cited by 124
Report on psychoactive drug use among adolescents using ayahuasca within a religious context.
Doering-Silveira, E., Grob, C. S., de Rios, M. D., Lopez, E., Alonso, L. K., Tacla, C., & Da Silveira, D. X. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399794 · Cited by 122
‘Altered States of Consciousness and Short-Term Psychological After-Effects Induced by the First Time Ritual Use of Ayahuasca in an Urban Context in Brazil’
Barbosa, P. C. R., Giglio, J. S., & Dalgalarrondo, P. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399801 · Cited by 120
Handbook of Exposure Therapies
Richard, D. C. S., & Lauterbach, D. (2007) · Elsevier eBooks · doi:10.1016/b978-0-12-587421-2.x5000-5 · Cited by 118
Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus
Réus, G. Z., Stringari, R. B., de Souza, B., Petronilho, F., Dal-Pizzol, F., Hallak, J. E., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.5.13109 · Cited by 110
A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects
Barbosa, P. C. R., Cazorla, I. M., Giglio, J. S., & Strassman, R. J. (2009) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2009.10400530 · Cited by 108
Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties
Fortunato, J. J., Réus, G. Z., Kirsch, T. R., Stringari, R. B., Fries, G. R., Kapczinski, F. P., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., & Quevedo, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.008 · Cited by 108
Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study
Riba, J., McIlhenny, E. H., Bouso, J. C., & Barker, S. A. (2014) · Drug Testing and Analysis · doi:10.1002/dta.1685 · Cited by 104
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat
Pic‐Taylor, A., da Motta, L. G., de Morais, J. A., Melo, W., Santos, A. D. F. A., Campos, L. A., Mortari, M. R., von Zuben, M. V., & Caldas, E. D. (2015) · Behavioural Processes · doi:10.1016/j.beproc.2015.05.004 · Cited by 102
Serotonergic psychedelics temporarily modify information transfer in humans.
Alonso, J. F., Romero, S., Mañanas, M. À., & Riba, J. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv039 · Cited by 101
The Therapeutic Use of Ayahuasca
Labate, B., & Cavnar, C. (2014) · Springer eBooks · doi:10.1007/978-3-642-40426-9 · Cited by 99
Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus
Fortunato, J. J., Réus, G. Z., Kirsch, T. R., Stringari, R. B., Fries, G. R., Kapczinski, F., Hallak, J. E., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0451-2 · Cited by 98
Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice
Kłodzińska, A., Bijak, M., Tokarski, K., & Pilc, A. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00845-6 · Cited by 97
Assessing Decentering: Validation, Psychometric Properties, and Clinical Usefulness of the Experiences Questionnaire in a Spanish Sample
Soler, J., Franquesa, A., Feliu-Soler, A., Cebolla, A., García-Campayo, J., Tejedor, R., Demarzo, M., Baños, R., Pascual, J. C., & Portella, M. J. (2014) · Behavior Therapy · doi:10.1016/j.beth.2014.05.004 · Cited by 92 · cited 7×
“, 2014) and borderline personality disorders (Soler et al., 2014).”
BackgroundMethodInfluential
Untitled work
(2007) · Cited by 92
Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice.
Oliveira-Lima, A. J., Santos, R., Hollais, A. W., Gerardi-Junior, C. A., Baldaia, M. A., Wuo-Silva, R., Yokoyama, T. S., Costa, J. L., Malpezzi-Marinho, E. L. A., Ribeiro-Barbosa, P. C., et al. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.01.032 · Cited by 91
Indole Alkaloids of Acer saccharinum (the Silver Maple), Dictyoloma incanescens, Piptadenia colubrina, and Mimosa hostilis
Pachter, I. J., Zacharias, D. E., & Ribeiro, O. (1959) · The Journal of Organic Chemistry · doi:10.1021/jo01091a032 · Cited by 91
Pharmacotheon: entheogenic drugs, their plant sources and history
(1994) · Choice Reviews Online · doi:10.5860/choice.31-3245 · Cited by 91
Hypotheses Regarding the Mechanisms of Ayahuasca in the Treatment of Addictions
Liester, M. B., & Prickett, J. I. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.704590 · Cited by 87
Piptadenia Alkaloids. Indole Bases of P. peregrina (L.) Benth. and Related Species
Fish, M. S., Johnson, N. M., & Horning, E. C. (1955) · Journal of the American Chemical Society · doi:10.1021/ja01627a034 · Cited by 84
Decentering as a potential common mechanism across two therapies for generalized anxiety disorder
Hayes-Skelton, S. A., Calloway, A., Roemer, L., & Orsillo, S. M. (2015) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0038305 · Cited by 83 · cited 2×
“…(Bieling et al., 2012; Fresco et al., 2007b; Gecht, 2014; Hargus et al., 2010; Teasdale et al., 2002), but also in generalized anxiety disorder (Hayes-Skelton et al., 2015; Hoge et al., 2015), social anxiety (Hayes-Skelton and Graham, 2013), eating disorders, substance use disorders (Shapiro…”
Background
Exploring the relationship between facets of mindfulness and eating pathology in women
Lavender, J. M., Gratz, K. L., & Tull, M. T. (2011) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2011.555485 · Cited by 83 · cited 1×
“These findings are of special interest, if we consider that psychiatric populations score lower than healthy individuals on trait mindfulness (Cardaciotto et al., 2008; Lavender et al., 2011; Tejedor et al., 2014).”
Background
Harmane Induces Anxiolysis and Antidepressant‐Like Effects in Rats
Arıcıoğlu, F., & Altunbas, H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1304.024 · Cited by 83
The healing practices of a peruvian shaman
Luna, L. E. (1984) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(84)90035-7 · Cited by 80
Salutary Proximal Processes and Distal Mood and Anxiety Vulnerability Outcomes of Mindfulness Training: A Pilot Preventive Intervention
Tanay, G., Lotan, G., & Bernstein, A. (2012) · Behavior Therapy · doi:10.1016/j.beth.2011.06.003 · Cited by 78 · cited 2×
“Decentering, also called “defusion”, is considered a byproduct of mindfulness practice (Gecht et al., 2014; Tanay et al., 2012) and refers to the ability to observe one‟s own thoughts and feelings in a detached manner.”
Background
A mediation model of mindfulness and decentering: sequential psychological constructs or one and the same?
Gecht, J., Kessel, R., Forkmann, T., Gauggel, S., Drueke, B., Scherer, A., & Mainz, V. (2014) · BMC Psychology · doi:10.1186/2050-7283-2-18 · Cited by 78
Agonist-Trafficking and Hallucinogens
González‐Maeso, J., & Sealfon, S. C. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581851 · Cited by 75
Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors
Gewirtz, J. C., Chen, A. C. H., Terwilliger, R. Z., Duman, R. C., & Marek, G. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00844-4 · Cited by 74
Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease
Wang, Y., Samoylenko, V., Tekwani, B. L., Khan, I. A., Miller, L. S., Chaurasiya, N. D., Rahman, M. M., Tripathi, L. M., Khan, S. I., Joshi, V. C., et al. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.02.013 · Cited by 74
Posttraumatic stress disorder in incarcerated women: A call for evidence-based treatment.
Harner, H. M., Budescu, M., Gillihan, S. J., Riley, S., & Foa, E. B. (2013) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/a0032508 · Cited by 73
Inhibition by β-carbolines of monoamine uptake into a synaptosomal preparation: Structure-activity relationships
Buckholtz, N. S., & Boggan, W. O. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90190-4 · Cited by 72
New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca
McKenna, D. J., & Jordi Riba, A. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_472 · Cited by 69
Induction of early growth response gene 2 expression in the forebrain of mice performing an attention-set-shifting task
DeSteno, D. A., & Schmauss, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.012 · Cited by 66
Facing the Dreaded: Does Mindfulness Facilitate Coping with Distressing Experiences? A Moderator Analysis
Bergomi, C., Ströhle, G., Michalak, J., Funke, F., & Berking, M. (2013) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2012.713391 · Cited by 58 · cited 1×
“Analogous benefits in these three psychological domains have been observed in meditators, with a direct association between enhanced mindfulness capacities and the frequency and lifetime practice of meditation (Bergomi et al., 2013; Soler et al., 2014).”
Background
Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice
Dhonnchadha, B. Á. N., Hascoët, M., Jolliet, P., & Bourin, M. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00179-7 · Cited by 57
Using a Trauma‐Informed Framework to Care for Incarcerated Women
Harner, H. M., & Burgess, A. W. (2011) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/j.1552-6909.2011.01259.x · Cited by 52
Effects of harmaline on anxiety-related behavior in mice
Hilber, P., & Chapillon, P. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.07.006 · Cited by 52
Plants of the Gods: Origins of Hallucinogenic Use
Liskow, B. I. (1980) · JAMA · doi:10.1001/jama.1980.03310170076041 · Cited by 51
A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions
SANTOS, R. G. D. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.785846 · Cited by 50
Simultaneous Cerebral Glucography with Positron Emission Tomography and Topographic Electroencephalography
Buchsbaum, M. S., KESSLER, R. M., King, A. C., Johnson, J., & Cappelletti, J. (1984) · Progress in brain research · doi:10.1016/s0079-6123(08)62182-2 · Cited by 48
Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice
Mazur‐Kolecka, B., Golabek, A. A., Kida, E., Rabe, A., Hwang, Y., Adayev, T., Węgiel, J., Flory, M. J., Kaczmarski, W., Marchi, E. J., et al. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23007 · Cited by 44
Administration of Harmine and Imipramine Alters Creatine Kinase and Mitochondrial Respiratory Chain Activities in the Rat Brain
Réus, G. Z., Stringari, R. B., Gonçalves, C. L., Scaini, G., Carvalho‐Silva, M., Jeremias, G. C., Jeremias, I. C., Ferreira, G. K., STRECK, E. L., Hallak, J. E. C., et al. (2011) · Depression Research and Treatment · doi:10.1155/2012/987397 · Cited by 43
The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain
Frankel, P. S., & Cunningham, K. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03548-5 · Cited by 41
Acceptance and Commitment Therapy for drug abuse in incarcerated women
Villagrá Lanza, P., & González Menéndez, A. (2013) · Psicothema · doi:10.7334/psicothema2012.292 · Cited by 39
The therapeutic potentials of Ayahuasca in the treatment of depression
Palhano-Fontes, F., Alchieri, J. C., Oliveira, J. P. M., Soares, B. L., Hallak, J. E. C., Galvao-Coelho, N., & de Araujo, D. B. (2014) · The Therapeutic Use of Ayahuasca · doi:10.1007/978-3-642-40426-9_2 · Cited by 36
Propiedades psicométricas de la versión española de la Philadelphia Mindfulness Scale
Tejedor, R., Feliu‐Soler, A., Pascual, J. C., Cebolla, A., Portella, M. J., Trujols, J., Soriano, J., Pérez, V., & Soler, J. (2014) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2014.04.001 · Cited by 33
Extinction of aversive eliciting functions as an analog of exposure to conditioned fear: Does it alter avoidance responding?
Luciano, C., Valdivia-Salas, S., Ruiz, F. J., Rodríguez-Valverde, M., Barnes-Holmes, D., Dougher, M., Cabello, F., Sánchez, V., Barnes-Holmes, Y., & Gutiérrez, O. (2013) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2013.05.001 · Cited by 32
Dialektisch Behaviorale Therapie für Posttraumatische Belastungsstörung nach sexualisierter Gewalt in der Kindheit und Jugend (DBT-PTSD)
Bohus, M., Dyer, A., Priebe, K., Krüger, A., & Steil, R. (2010) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/s-0030-1263162 · Cited by 31
New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca
McKenna, D. J., & Riba, J. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_368 · Cited by 31
Les effets de l’ayahuasca sur le système nerveux central: étude comportementale
de Lima, L. M. S., Ferreira, S. M., Ávila, A. A. L., Perazzo, F. F., Schneedorf, J. M., Hinsberger, A., & Carvalho, J. C. T. (2007) · Phytothérapie · doi:10.1007/s10298-007-0266-y · Cited by 27
Interventions basées sur la pleine conscience en addictologie
Skanavi, S., Laqueille, X., & Aubin, H. (2011) · L Encéphale · doi:10.1016/j.encep.2010.08.010 · Cited by 26
Altered states and the study of consciousness: The case of Ayahuasca
Shanon, B. (2003) · The Journal of mind and behavior · Cited by 26
Posttraumatic growth and posttraumatic stress disorder in Veterans
Moran, S., Burker, E. J., & Schmidt, J. V. (2013) · Journal of rehabilitation · Cited by 25
Human pharmacology of ayahuasca
Riba, J. (2003) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 25
Alkaloid content of Banisteriopsis rusbyana.
Agurell, S., Holmstedt, B. R., & Lindgren, J. E. (1969) · PubMed · Cited by 23
Ayahuasca psychedelic tested for depression
Frood, A. (2015) · Nature · doi:10.1038/nature.2015.17252 · Cited by 20
Post-traumatic Stress Disorder
Newman, M. (2001) · Elsevier eBooks · doi:10.1016/b0-08-043076-7/03758-x · Cited by 18
Psychometric properties of the Spanish version of the Philadelphia Mindfulness Scale
Tejedor, R., Feliu‐Soler, A., Pascual, J. C., Cebolla, A., Portella, M. J., Trujols, J., Soriano, J., Pérez, V., & Soler, J. (2014) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2014.10.002 · Cited by 17
The Effect of Globopentaosylceramide on a Depression Model, Mouse Forced Swimming
Masuda, Y., & Sugiyama, T. (2000) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.191.47 · Cited by 14
Effect of Santo Daime Membership on Substance Dependence
Labate, B. C., SANTOS, R. G. D., Strassman, R. J., Anderson, B. T., & Mizumoto, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_9 · Cited by 13
Therapeutic Applications of Ayahuasca and Other Sacred Medicines
Winkelman, M. (2013) · Springer eBooks · doi:10.1007/978-3-642-40426-9_1 · Cited by 11
Exposure therapy and cognitive interventions for the anxiety disorders
Forsyth, J. P., Barrios, V., & Acheson, D. T. (2007) · Elsevier eBooks · doi:10.1016/b978-012587421-2/50004-1 · Cited by 11

Sorted by citations

Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269
“When DMT is administered without the other ayahuasca components, effects arise within minutes after ingestion when inhaled or injected, and last for 15min (15).”
Background
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT
Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214377 · Cited by 268
Assessing the psychedelic "after-glow" in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities
Sampedro, F., de la Fuente Revenga, M., Valle, M., Roberto, N., Domínguez-Clavé, E., Elices, M., Luna, L. E., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx036 · Cited by 200
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
Kuypers, K. P. C., Riba, J., de la Fuente Revenga, M., Barker, S., Theunissen, E. L., & Ramaekers, J. G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4377-8 · Cited by 201
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
Hamill, J., Hallak, J. E. C., Dursun, S. M., & Baker, G. B. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180125095902 · Cited by 201

See all 226

Authors: Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., Friedlander, P., Feilding, A., & Riba, J.
Affiliations: Universitat Autònoma de Barcelona (ES)
Beckley Foundation (GB)
ORCID: Soler, Joaquim
Elices, Matilde
Pascual, Juan C.
Feilding, Amanda
Venue: Brain Research Bulletin
Publisher: Elsevier BV
Published: 2016-09
Volume: 126
Issue: Pt 1
Pages: 89-101
ISSN: 0361-9230 (ISSN-L)
DOI: 10.1016/j.brainresbull.2016.03.002
OpenAlex: W2301686735
Cited by: 226
References: 139
Citations by year: 2026: 17 · 2025: 27 · 2024: 22 · 2023: 16 · 2022: 29 · 2021: 28 · 2020: 29 · 2019: 18 · 2018: 25 · 2017: 9 · 2016: 4
FWCI: 2.76
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Brain Research Bulletin (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
Physical Sciences › Chemistry › Organic Chemistry › Synthesis and bioactivity of alkaloids
Keywords: ayahuasca, Banisteriopsis caapi, Psychotria viridis, N,N-dimethyltryptamine, β-carbolines, monoamine oxidase inhibition, psychedelics, altered states of consciousness, substance use disorders, anxiety, depression, mindfulness, self-acceptance, trauma, personality disorders, impulse control disorders, therapeutic potential
MeSH terms: Animals, Carbolines, Humans, Neurosciences, Pharmacology, Plant Extracts, Banisteriopsis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Ayahuasca: Pharmacology, neuroscience and therapeutic potential

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks